QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Writing the Actions Taken for Safety Reasons Section in a PBRER

Test your understanding of the concepts covered by Writing the Actions Taken for Safety Reasons Section in a PBRER.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Several measures are introduced in response to one hepatotoxicity concern: SmPC changes, a DHPC, educational material and enhanced liver monitoring. How should they generally be presented?

As four unrelated events listed only by implementation date As one coordinated regulatory response grouped around the underlying safety concern Only the SmPC change should be included because the other measures are operational Only the DHPC should be included because communications are the formal action

Question 2 of 10 Which statement best reflects the required tone when describing a safety action supported by incomplete evidence?

Use definitive language to demonstrate confidence in the company’s position Use objective, evidence-based wording that acknowledges uncertainty where it remains Emphasise the commercial benefits of the action Criticise authorities if their decision differs from the company’s assessment

Question 3 of 10 Which statement best reflects the treatment of a quality defect in this section?

Quality issues are always excluded, even when they create a patient safety risk The section should provide the full manufacturing investigation and root-cause analysis The section should focus on safety-related actions, such as a recall or monitoring, while detailed manufacturing investigation belongs elsewhere Any manufacturing change should automatically be classified as a safety action

Question 4 of 10 Two countries implement different measures for the same safety concern during the reporting interval. What is the most appropriate presentation?

Report only the stricter measure to simplify the narrative Present the differences objectively, including geographical scope and known reasons where relevant Assume that the later decision supersedes the earlier decision everywhere Describe every procedural step in each country regardless of relevance

Question 5 of 10 What is the most appropriate treatment of a routine safety newsletter that was issued without a specific safety concern?

Include it as a regulatory communication because it discusses safety generally Include it as a DHPC regardless of its content Generally exclude it from this section because it was not prompted by a specific safety concern Classify it as a marketing authorisation action

Question 6 of 10 Which event best illustrates a regulatory action that should normally be included?

Transfer of the marketing authorisation to another company for strategic reasons Routine correction of a typographical error in the Package Leaflet Introduction of a contraindication following evaluation of an identified risk Change of distributor without any effect on product safety

Question 7 of 10 Why should unrelated safety actions generally be described separately?

To ensure that every action is written with exactly the same level of detail To avoid implying that different actions arose from the same scientific concern To prevent regional implementation information from being included To replace scientific rationale with a purely chronological account

Question 8 of 10 A product is withdrawn from one country because sales volumes are persistently low, with no safety concern involved. How should this event generally be handled?

Include it as a major safety action because the product is no longer available Include it as a safety action but state that no safety concern was identified Exclude it from this section and consider reporting it in the worldwide marketing authorisation status Include it under risk minimisation because withdrawal reduces exposure

Question 9 of 10 A company voluntarily strengthens a warning after its internal signal evaluation, before a formal authority request. Should the action be considered for inclusion?

No, because only authority-requested measures qualify Yes, because the relevant criterion is the safety basis of the action, not who initiated it No, unless the action results in a marketing authorisation suspension Yes, but only in the commercial section of the PBRER

Question 10 of 10 A national authority introduces additional laboratory monitoring, while other regions retain existing recommendations. What should the PBRER narrative do?

State that all regions adopted the additional monitoring Omit the national measure because it is not globally harmonised Identify the regional scope and objectively describe the differing implementation Treat the difference as evidence that one authority made an error

QPPV.com

Knowledge Assessment: Writing the Actions Taken for Safety Reasons Section in a PBRER

Cookie Settings